4 ms·

Moderna is starting development on an omicron-specific vaccine, as well as testing their other vaccine variants. I wonder if maybe the manufacturing data requi

• mdp2021 5y ago
  > Moderna is starting development on an omicron-specific vaccine Also the Novavax producers. RSS feeds hours ago were full of "ready in 100 days" expressions; as I am making posts-vetting checks on search engines I am seeing one «would have the shot ready for testing and manufacturing in the next few weeks» (https://www.straitstimes.com/world/united-states/novavax-testing-vaccine-that-targets-new-omicron-covid-19-variant https://www.straitstimes.com/world/united-states/novavax-tes...).
• jeremyjh 5y ago
  Do we know that a "minor version update" could never cause a problem like the 1976 Swine Flu vaccine that was rushed to mass deployment and killed far more people than that flu did?
  • rsfern 5y ago
    Right, there’s not way to know that without the clinical trials that are required even for small formulation changes, our quantitative understanding of biology is not that good. But there’s plenty of supply chain and manufacturing aspects of the approval that seem like wouldn’t need any more stringency than the ongoing monitoring for the currently approved vaccines, from my lay persons perspective anyway